Mental health, disability in the justice system
Gaze aversion, lack of emotional expression, repetitive body movements, or speaking in monologue tone can sway people’s judgement of another’s credibility and honesty – notably in […]
Targeting new drugs for schizophrenia
Flinders University researchers have investigated how an antipsychotic drug currently in the development stage binds to its intended target, potentially paving the way for the design […]
Artificial intelligence to support mental health
New AI software developed by researchers at Flinders University shows promise for enabling timely support ahead of relapse in patients with severe mental illness. The AI2 […]
New approach to ‘thinking errors’
Promising results with a psychotherapy program for people with psychosis is leading researchers to look for ways to adapt it for other conditions such as eating […]
Research seeks child’s eye insights to cast light on autism
Inspired by his son, Flinders optometry researcher Dr Paul Constable has commenced working with Yale Child Study Center and Great Ormond Street Children’s Hospital on links […]
Dynamin: a new tool to tackle neurological disorders
Neuroscientists at Flinders University have identified a series of chemical tools that can either increase or inhibit the release of neurotransmitters by neurons.
UK grant for anti-psychotic drug study
Olanzapine, used to treat schizophrenia and bipolar disorder, will come under the microscope in a new study.